Growth hormone-releasing hormone antagonists abolish the transactivation of human epidermal growth factor receptors in advanced prostate cancer models

1. Muñoz-Moreno, L.
2. Arenas, M.I.
3. Carmena, M.J.
4. Schally, A.V.
5. Prieto, J.C.
6. Bajo, A.M.